To: Head of the FDA
Tell FDA to supervise compound labs
We, the undersigned, ask the FDA to begin supervising the production of compounds at previously non-overseen laboratories. The imperative of 47 people infected with fungal meningitis in 7 states makes this an issue that should be addressed immediately.
Why is this important?
With 47 people in 7 states getting meningitis from fungus growing in steroids produced in non-FDA supervised pharmacy labs, it is time for the FDA to take over supervision of those compound-producing laboratories. Add your voice to encourage the FDA to protect us from bad drugs.